32 related articles for article (PubMed ID: 34915342)
1. Acquired immune resistance is associated with interferon signature and modulation of KLF6/c-MYB transcription factors in myeloid leukemia.
Parveen M; Karaosmanoglu B; Sucularli C; Uner A; Taskiran EZ; Esendagli G
Eur J Immunol; 2024 May; 54(5):e2350717. PubMed ID: 38462943
[TBL] [Abstract][Full Text] [Related]
2. Ludwig LS, Lareau CA, Bao EL, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139(16):2534-2546.
Blood; 2023 Mar; 141(9):1094. PubMed ID: 36862429
[No Abstract] [Full Text] [Related]
3. Steiner L. Helping GATA1 make complex decisions. Blood. 2022;139(24):3457-3459.
Blood; 2022 Sep; 140(13):1571. PubMed ID: 36173657
[No Abstract] [Full Text] [Related]
4. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM; Suttorp J; Walter C; Antoniou E; Behrens YL; Göhring G; Awada A; von Neuhoff N; Reinhardt D; Schneider M
Leukemia; 2024 Mar; 38(3):538-544. PubMed ID: 38086945
[TBL] [Abstract][Full Text] [Related]
5. c-MYB and DMTF1 in Cancer.
Fry EA; Inoue K
Cancer Invest; 2019; 37(1):46-65. PubMed ID: 30599775
[TBL] [Abstract][Full Text] [Related]
6. Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants.
Quelen C; Lippert E; Struski S; Demur C; Soler G; Prade N; Delabesse E; Broccardo C; Dastugue N; Mahon FX; Brousset P
Blood; 2011 May; 117(21):5719-22. PubMed ID: 21474671
[TBL] [Abstract][Full Text] [Related]
7. A Case of Congenital Leukemia With MYB-GATA1 Fusion Gene in a Female Patient.
Ozono S; Yano S; Oishi S; Mitsuo M; Nakagawa S; Toki T; Terui K; Ito E
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e250-e252. PubMed ID: 33661169
[TBL] [Abstract][Full Text] [Related]
8. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
9. MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors.
Ducassou S; Prouzet-Mauléon V; Deau MC; Brunet de la Grange P; Cardinaud B; Soueidan H; Quelen C; Brousset P; Pasquet JM; Moreau-Gaudry F; Arock M; Mahon FX; Lippert E
J Pathol; 2017 Jul; 242(3):347-357. PubMed ID: 28418072
[TBL] [Abstract][Full Text] [Related]
10. In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels.
Belloni E; Shing D; Tapinassi C; Viale A; Mancuso P; Malazzi O; Gerbino E; Dall'Olio V; Egurbide I; Odero MD; Bertolini F; Pelicci PG
Leukemia; 2011 Apr; 25(4):733-6. PubMed ID: 21252985
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis.
Kovach AE; Zerkalenkova E; Zemtsova L; Borkovskaya A; Gaskova M; Kazanov M; Popov A; Baidun L; Maschan M; Maschan A; Gaynon PS; Bhojwani D; Novichkova G; Olshanskaya Y; Raca G
Cancer Genet; 2022 Jan; 260-261():37-40. PubMed ID: 34915342
[TBL] [Abstract][Full Text] [Related]
12. Acute Basophilic Leukemia: Recent Molecular and Diagnostic Update.
Singh G
Cureus; 2022 Jun; 14(6):e26054. PubMed ID: 35865433
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]